Expect to Hear About Renal Protection With Flozins and GLP-1 Agonists

September 2018

You'll hear buzz about using SGLT2 inhibitors (Jardiance, etc) or GLP-1 agonists (Victoza, etc) to protect the kidneys in type 2 diabetes.

We know ACE inhibitors or ARBs slow progression of nephropathy in diabetes patients with hypertension and albuminuria.

Now data suggest Jardiance (empagliflozin) or Invokana (canagliflozin) may have some kidney protective effects...probably by lowering intraglomerular pressure.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote